Gujarat Inject Kerala Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company has notified BSE that its Board of Directors will meet on May 20, 2026 to consider and approve the audited standalone financial results for the quarter and full year ended March 31, 2026. The meeting will also review the statutory auditors' report on these results. This is a routine regulatory filing under SEBI Listing Regulations. The actual financial numbers and any audit qualifications have not been disclosed in this notice as the meeting has not yet taken place.
This is a standard pre-result announcement notice and does not contain any new financial information or red flags. Shareholders should await the actual results on May 20, 2026 for any meaningful assessment of company performance.